Cleared Special

K122729 - ABL90 FLEX

K122729 is the FDA 510(k) clearance for ABL90 FLEX by Radiometer Medical Aps. It is a Class 2 Chemistry device (product code CHL) cleared through the Special 510(k) pathway after a 71-day FDA review.

K122729 · Radiometer Medical Aps · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2012
Decision
71d
Days
Class 2
Risk

K122729 is an FDA 510(k) clearance for the ABL90 FLEX. Classified as Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph (product code CHL), Class II - Special Controls.

Submitted by Radiometer Medical Aps (Bronshoj, DK). The FDA issued a Cleared decision on November 16, 2012 after a review of 71 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1120 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Radiometer Medical Aps devices

Submission Details

510(k) Number K122729 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 06, 2012
Decision Date November 16, 2012
Days to Decision 71 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
17d faster than avg
Panel avg: 88d · This submission: 71d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code CHL Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1120
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CHL Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph

All 119
Devices cleared under the same product code (CHL) and FDA review panel - the closest regulatory comparables to K122729.
NOVA STAT PROFILE PRIME CCS ANALYZER SYSTEM
K131703 · Nova Biomedical Corporation · Mar 2014
GEM PREMIER 4000
K133407 · Instrumentation Laboratory CO · Jan 2014
MEASUREMENT OF PH IN PLEURAL FLUID ON BLOOD GAS SYSTEM
K122539 · Siemens Healthcare Diagnostics · Apr 2013
COBAS B 123 POC SYSTEM, COBAS B 123 AUTOQC PACK TRI-LEVEL, COBAS B 123 AUTOCVC PACK, ROCHE COMBITROL PLUS B
K111188 · Roche Diagnostics · May 2012
NOVA STAT PROFILE PHOX ULTRA ANALYZER SYSTEM
K110648 · Nova Biomedical Corporation · Aug 2011
EASYSTAT PH, PCO2, PO2, HTC, NA, K, CL ANALYZER
K063376 · Medica Corp. · Jun 2007